As part of its partnership agreement with Université Paris-Sud XI, the Institut Gustave Roussy has created and houses the School of Cancerology and the Graduate School of Cancerology (Ecole Doctorale de Cancérologie).
The School of Cancerology provides more than 5,000 hours of classes per year involving more than 2,500 physicians, researchers and paramedics. One of the key strengths of the School of Cancerology is its multi-discipline offering: physicians, researchers, surgeons, biologists, radiologists and radiotherapists all make their practical and theoretical knowledge available to students of all disciplines – medical or paramedical – and at all levels.
The Graduate school of Cancerology provides doctoral students with vocational skills training the field of cancerology.
The IGR also hosts the IFSBM (Institute of Higher Education in Biomedical Science) for research students more oriented towards the needs of industry. Many of the EFEC (European Cancerology Training School) classes are held at the IGR
In 2010 Cancer Campus® and SupBiotech signed a partnership agreement to strengthen their relationship by initiating and developing large-scale collaborative projects.
SupBiotech is in the immediate vicinity of the campus – the school is located opposite the enterprise centre/business hotel.
Cancer Campus® has signed a partnership agreement with Université Paris VI whereby students at the campus are fast-tracked to a graduate-level diploma (Diplôme d'Université or DU for short), in biomedical engineering and specifically in "the development of research and biomedical innovation". The teaching element of this DU covers all aspects of applied research development, from initial idea to marketed product, and addresses the socio-economic and regulatory healthcare environment influencing the market, as well as the creation of innovative businesses. The goals of the course are to: raise awareness of the socio-economic and regulatory healthcare environment with regard to working with or in the biomedical industry – enable innovation to be transferred to industry – encourage business start-ups resulting from research – publicise the rules governing research development – encourage businesses to work with academic biomedical research
More info click here
Photo credits: IGR/SupBiotech
